Back Login for AI Analysis

    LLY (STOCKS)

    Eli Lilly & Co.

    $1,015.000000
    -10.000000 (-0.98%)
    Prev close: $1,025.000000
    Company Information
    Exchange
    XNYS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    David A. Ricks
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $959,309.51M
    Employees
    47,000
    P/E (TTM)
    44.66
    P/B (TTM)
    40.75
    Dividend Yield
    58.54%
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Sep 2025)
    Revenues $59.42B
    Benefits Costs and Expenses $36.92B
    Cost Of Revenue $10.08B
    Costs And Expenses $36.92B
    Gross Profit $49.34B
    Nonoperating Income/Loss -$572.80M
    Operating Expenses $26.83B
    Selling, General, and Administrative Expenses $10.39B
    Other Operating Expenses $16.45B
    Operating Income/Loss $22.50B
    Income/Loss From Continuing Operations After Tax $18.41B
    Income/Loss From Continuing Operations Before Tax $22.50B
    Income Tax Expense/Benefit $4.09B
    Net Income/Loss $18.41B
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent $18.41B
    Net Income/Loss Available To Common Stockholders, Basic $18.41B
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share $20.49
    Diluted Earnings Per Share $20.44
    Basic Average Shares 897,505,000
    Diluted Average Shares 1,798,659,000
    Assets $114.94B
    Current Assets $62.07B
    Inventory $12.18B
    Prepaid Expenses $20.25B
    Other Current Assets $29.64B
    Noncurrent Assets $52.86B
    Fixed Assets $22.32B
    Intangible Assets $6.45B
    Other Non-current Assets $24.10B
    Liabilities $91.08B
    Current Liabilities $40.14B
    Accounts Payable $4.26B
    Wages $1.97B
    Other Current Liabilities $33.91B
    Noncurrent Liabilities $50.94B
    Equity $23.85B
    Equity Attributable To Noncontrolling Interest $57.50M
    Equity Attributable To Parent $23.79B
    Liabilities And Equity $114.94B
    Net Cash Flow From Operating Activities $16.06B
    Net Cash Flow From Operating Activities, Continuing $16.06B
    Net Cash Flow From Investing Activities -$10.09B
    Net Cash Flow From Investing Activities, Continuing -$10.09B
    Net Cash Flow From Financing Activities $440.40M
    Net Cash Flow From Financing Activities, Continuing $440.40M
    Exchange Gains/Losses $10.60M
    Net Cash Flow $6.42B
    Net Cash Flow, Continuing $6.41B
    Comprehensive Income/Loss $19.48B
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent $19.48B
    Other Comprehensive Income/Loss $25.66B
    Other Comprehensive Income/Loss Attributable To Parent $1.07B